Catalyst Pharmaceuticals Inc. stock rises Tuesday, outperforms market

Shares of Catalyst Pharmaceuticals Inc. CPRX, +4.51% rose 4.51% to $12.06 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, +0.36% rising 0.36% to 13,276.42 and the Dow Jones Industrial Average DJIA, +0.03% rising 0.03% to 33,573.28.

The stock's rise snapped a two-day losing streak.

Catalyst Pharmaceuticals Inc. closed $10.05 below its 52-week high ($22.11), which the company achieved on January 13th.

The stock outperformed some of its competitors Tuesday, as Johnson & Johnson JNJ, -0.09% fell 0.09% to $158.18, Pfizer Inc. PFE, -0.72% fell 0.72% to $38.37, and Abbott Laboratories ABT, -1.10% fell 1.10% to $102.62.

Trading volume (1.6 M) remained 323,501 below its 50-day average volume of 1.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Citigroup says investors are reaching a tipping point in their bullishness on tech stocks.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.